Genetic Evaluation and Modification of Lifestyles to Improve Female Life Expectancy

NCT05715372 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2023-02-13

No results posted yet for this study

Summary

The GEMLIFE Study is a 12-month clinical trial for menopausal women. The purpose of this study is to promote an improved aging process for women in menopause through lifestyle changes. The changes will include a heart healthy diet, structured walking program, and mindfulness-based stress reduction. During the study, the investigators will monitor components of your genetic make-up that will tell us how you are aging. Investigators will also monitor bloodwork for inflammation that can affect medical conditions. Study participants may qualify if you are within 5 years of your last menstrual period and have well controlled medical conditions. There is no cost to participants to enroll in the study- only potential benefits to the participant's health and aging process.

Conditions

  • Menopause Syndrome
  • Inflammation
  • Inflammatory Response
  • Aging
  • Menopause
  • Telomere Shortening
  • Stress Oxidative

Interventions

BEHAVIORAL

Mediterranean diet

12-week structured program for Mediterranean diet.

BEHAVIORAL

AHA walking program

12-week structured AHA walking program.

BEHAVIORAL

Mindfulness-based stress reduction

8-week structured mindfulness-based stress reduction (Cabot).

BEHAVIORAL

Unstructured Mediterranean diet

Unstructured 12-week program with basic outline for Mediterranean diet.

BEHAVIORAL

Unstructured walking program

Unstructured 12-week walking program.

BEHAVIORAL

Unstructured stress reduction

Unstructured program using mobile application for stress reduction.

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Barbara Soltes, MD · Rush University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
40 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-06-22
Primary Completion
2021-06-22
Completion
2021-06-22

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05715372 on ClinicalTrials.gov